Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 14 | 16 | 12 | 29 | 29 |
| Gross Profit | 14 | 16 | 12 | 29 | 29 |
| Operating Expenses | 2,320 | 2,225 | 2,033 | 2,319 | 2,548 |
| Operating Income | -2,306 | -2,209 | -2,021 | -2,290 | -2,519 |
| Other Income | 2 | 3 | 15 | 6 | 11 |
| Pre-tax Income | -2,304 | -2,206 | -2,006 | -2,284 | -2,508 |
| Net Income Continuous | -2,304 | -2,206 | -2,006 | -2,284 | -2,508 |
| Net Income | $-2,304 | $-2,206 | $-2,006 | $-2,284 | $-2,508 |
| EPS Basic Total Ops | -0.07 | -0.17 | -0.23 | -0.32 | 0.57 |
| EPS Basic Continuous Ops | -0.09 | -0.13 | -0.14 | -0.18 | 0.53 |
| EPS Diluted Total Ops | -0.07 | -0.17 | -0.23 | -0.32 | 0.57 |
| EPS Diluted Continuous Ops | -0.09 | -0.13 | -0.14 | -0.18 | 0.53 |
| EBITDA(a) | $-2,287 | $-2,183 | $-2,001 | $-2,268 | $-2,498 |